- Home
- ESPR vs NGS Comparison
ESPR vs NGS Comparison
Compare ESPR & NGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ESPR | NGS |
|---|---|---|
| Founded | 2008 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 898.5M | 420.9M |
| IPO Year | 2013 | 2002 |
Fundamental Metrics
Financial Performance| Metric | ESPR | NGS |
|---|---|---|
| Price | $4.00 | $32.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $6.67 | ★ $35.67 |
| AVG Volume (30 Days) | ★ 6.8M | 88.7K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | ★ 1.35% |
| EPS Growth | N/A | ★ 14.85 |
| EPS | N/A | ★ 1.47 |
| Revenue | ★ $303,802,000.00 | $166,824,000.00 |
| Revenue This Year | $25.45 | $9.50 |
| Revenue Next Year | N/A | $13.88 |
| P/E Ratio | ★ N/A | $22.07 |
| Revenue Growth | 2.83 | ★ 9.53 |
| 52 Week Low | $0.69 | $16.73 |
| 52 Week High | $4.13 | $33.82 |
Technical Indicators
Market Signals| Indicator | ESPR | NGS |
|---|---|---|
| Relative Strength Index (RSI) | 60.61 | 56.97 |
| Support Level | $3.63 | $31.51 |
| Resistance Level | $4.13 | $33.15 |
| Average True Range (ATR) | 0.21 | 1.07 |
| MACD | -0.03 | -0.17 |
| Stochastic Oscillator | 60.19 | 54.27 |
Price Performance
Historical ComparisonAbout ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.